Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  DaShenLin Pharmaceutical Group Co., Ltd.    603233   CNE100002RG2

DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

(603233)
  Report
End-of-day quote. End-of-day quote SHANGHAI STOCK EXCHANGE - 02/19
54.01 CNY   -3.98%
 SummaryQuotesChartsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
02/13/2020 02/14/2020 02/17/2020 02/18/2020 02/19/2020 Date
55.43(c) 55(c) 56.69(c) 56.25(c) 54.01(c) Last
3 573 751 2 424 295 4 746 268 3 527 996 3 607 220 Volume
-2.38% -0.78% +3.07% -0.78% -3.98% Change
More quotes
Financials (CNY)
Sales 2019 11 231 M
EBIT 2019 952 M
Net income 2019 711 M
Finance 2019 1 122 M
Yield 2019 1,20%
Sales 2020 13 621 M
EBIT 2020 1 114 M
Net income 2020 832 M
Finance 2020 1 404 M
Yield 2020 1,12%
P/E ratio 2019 39,6x
P/E ratio 2020 33,6x
EV / Sales2019 2,53x
EV / Sales2020 2,07x
Capitalization 29 541 M
More Financials
Company
DaShenLin Pharmaceutical Group Co., Ltd. is a China-based company principally engaged in the pharmaceutical retailing business. The Company's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products,... 
Sector
Drug Retailers
Calendar
04/27Earnings Release
More about the company
Surperformance© ratings of DaShenLin Pharmaceutical G
Trading Rating : Investor Rating :
More Ratings
Latest news on DASHENLIN PHARMACEUTICAL G

- No features available -

More news
News in other languages on DASHENLIN PHARMACEUTICAL G

- No features available -

More news
Sector news : Drug Retailers - NEC
02/19French judges step up Ghosn probe over palace party, Oman dealings
RE
02/19EXCLUSIVE : 'Made in Russia' passenger jet finds a single buyer, Aeroflot
RE
02/19Malaysian firm offers AI-based profiling of Chinese visitors for virus
RE
02/18StanChart commits $75 billion toward sustainable development goals
RE
02/18French finance minister warns Renault against job cuts, factory closures
RE
More sector news : Drug Retailers - NEC
Chart DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
Duration : Period :
DaShenLin Pharmaceutical Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DASHENLIN PHARMACEUTICAL G
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 49,26  CNY
Last Close Price 54,01  CNY
Spread / Highest target 16,9%
Spread / Average Target -8,80%
Spread / Lowest Target -34,5%
EPS Revisions
Managers
NameTitle
Guo Qiang Ke General Manager
Yun Feng Ke Chairman
Zhi Hui Chen Chairman-Supervisory Board
Kang Bao Ke Director
Jin Long Ke Director & Deputy General Manager
Sector and Competitors